Epaned FDA Approval History
Last updated by Judith Stewart, BPharm on July 9, 2019.
FDA Approved: Yes (First approved August 13, 2013)
Brand name: Epaned
Generic name: enalapril maleate
Dosage form: Oral Solution
Company: Azurity Pharmaceuticals, Inc.
Treatment for: High Blood Pressure, Heart Failure, Left Ventricular Dysfunction
Epaned (enalapril maleate) is an angiotensin-converting enzyme inhibitor indicated for the treatment of hypertension in adults and children older than one month, symptomatic heart failure, and asymptomatic left ventricular dysfunction.
Development timeline for Epaned
| Date | Article |
|---|---|
| Jan 10, 2017 | Approval Epaned (enalapril maleate) Oral Solution is Now Available |
| Sep 8, 2014 | Approval FDA Approves Two New Indications for Epaned, the First and Only Enalapril Powder for Oral Solution |
| Aug 14, 2013 | Approval FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
